CBA PHARMA Trademark

Trademark Overview

On Monday, November 19, 2018, a trademark application was filed for CBA PHARMA with the United States Patent and Trademark Office. The USPTO has given the CBA PHARMA trademark a serial number of 88199618. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 24, 2022. This trademark is owned by CBA Pharma, Inc.. The CBA PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Research and development of pharmaceuticals for the treatment of multi-drug resistant diseases, cancer, infectious diseases, malaria, tuberculosis, leishmania, AIDS, trypanosomiasis and amoebic dysentery
cba pharma

General Information

Serial Number88199618
Word MarkCBA PHARMA
Filing DateMonday, November 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesPharmaceutical drug development services; Research and development of pharmaceuticals for the treatment of multi-drug resistant diseases, cancer, infectious diseases, malaria, tuberculosis, leishmania, AIDS, trypanosomiasis and amoebic dysentery
Pseudo MarkCBA PHARMACY

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 7, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCBA Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, KY 40517
Party NameCBA Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, KY 40517

Trademark Events

Event DateEvent Description
Monday, January 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 12, 2021EXTENSION 4 GRANTED
Saturday, June 12, 2021EXTENSION 4 FILED
Saturday, June 12, 2021TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020EXTENSION 3 GRANTED
Monday, December 14, 2020EXTENSION 3 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Wednesday, June 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 15, 2020EXTENSION 2 GRANTED
Monday, June 15, 2020EXTENSION 2 FILED
Monday, June 15, 2020TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 8, 2019ASSIGNED TO LIE
Tuesday, March 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 21, 2019NON-FINAL ACTION E-MAILED
Thursday, February 21, 2019NON-FINAL ACTION WRITTEN
Thursday, February 21, 2019ASSIGNED TO EXAMINER
Friday, December 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 22, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharma development diseases drug tuberculosis malaria leishmania aids dysentery amoebic trypanosomiasis